Ameritas Advisory Services’s Zai Lab ZLAB Stock Holding History

Ameritas Advisory Services’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44K	Buy	+76	New	+$1.5K	﹤0.01%	1739

Other funds holding ZLAB

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Ameritas Advisory Services's ZLAB Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in Zai Lab (ZLAB) in Q2 2026: 76 shares worth $1.44K. The stake represents ﹤0.01% of the portfolio and ranks #1739 among its holdings.

93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

Ameritas Advisory Services held 76 shares of Zai Lab worth $1.44K as of Q2 2026.
Zai Lab was a new Ameritas Advisory Services position in Q2 2026.
Zai Lab made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1739 holding.
93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.